Oral bioavailability and pharmacokinetics of baquiloprim in dwarf goats.
J Lewicki, R F Maas, R F Witkamp, A S Van-Miert
Index: Res. Vet. Sci. 58(3) , 268-71, (1995)
Full Text: HTML
Abstract
The pharmacokinetics of baquiloprim at a dose of 8 mg kg-1 bodyweight were determined after its intravenous and intra-ruminal administration to seven healthy female dwarf goats. After intravenous injection, the plasma elimination curve showed a rapid distribution phase (mean [SD] t1/2 alpha 0.89 [0.4] hours). The mean volume of distribution at steady-state (Vdss) was 14.1 (2.7) litres kg-1 bodyweight. The mean elimination half-life (t1/2 beta) was 14.0 (2.3) hours. After intra-ruminal administration its maximum concentration in plasma (Cmax) was 0.09 (0.01 microgram ml-1 and this maximum was not reached until approximately 35 hours after administration. The systemic oral bioavailability, calculated up to 48 hours after dosing, was 33.7 (7.1) per cent. Owing to a prolonged absorption phase, the data from only four of the goats fitted reasonably to a compartmental model.
Related Compounds
Related Articles:
1996-09-01
[Appl. Parasitol. 37(3) , 168-76, (1996)]
Prevention of Eimeria alabamensis coccidiosis by a long-acting baquiloprim/sulphadimidine bolus.
1998-01-31
[Vet. Parasitol. 74(2-4) , 143-52, (1998)]
1994-01-01
[Vet. Microbiol. 38(3) , 255-62, (1994)]
1993-05-01
[Res. Vet. Sci. 54(3) , 372-8, (1993)]
1998-09-05
[Vet. Rec. 143(10) , 273-6, (1998)]